519 studies found for:    H1n1 | "Influenza, Human"
Show Display Options
Rank Status Study
1 Completed Study of Swine-Origin A/H1N1 Influenza Non-Adjuvanted Vaccine in Healthy Adults in India
Conditions: Influenza;   Pandemic Influenza;   Influenza A Virus, H1N1 Subtype
Intervention: Biological: A/H1N1 pandemic influenza vaccine (non- adjuvanted)
2 Completed Tolerability and Immunogenicity Study of FLUVAL P H1N1 Flu Vaccine of Omninvest in Children and Adolescents
Conditions: Novel 2009 Influenza H1N1;   Influenza, Human
Interventions: Biological: Vaccination with Fluval P monovalent influenza vaccine;   Biological: Vaccination with Fluval AB;   Biological: Vaccination with Fluval AB Novo
3 Completed A Study of Swine-origin A/H1N1 Influenza Vaccines in Healthy Europeans Children Aged 6 to 35 Months
Conditions: Influenza;   Swine-origin A/H1N1 Influenza
Interventions: Biological: Swine A/H1N1 influenza vaccine (split virion, inactivated);   Biological: Swine A/H1N1 influenza vaccine (split virion, inactivated + Adjuvant);   Biological: Swine A/H1N1 influenza vaccine (split virion, inactivated + adjuvant)
4 Completed A Study of Inactivated Swine-Origin A/H1N1 Influenza Vaccines in Healthy European Subjects Aged 3 to 17 Years
Conditions: Influenza;   Swine-origin A/H1N1 Influenza
Interventions: Biological: Swine A/H1N1 influenza vaccine (split virion, inactivated);   Biological: Swine A/H1N1 influenza vaccine (split virion, inactivated + Adjuvant)
5 Completed A Study of Swine-origin A/H1N1 Influenza Vaccines in Healthy European Adults and the Elderly
Conditions: Influenza;   Swine-origin A/H1N1 Influenza
Interventions: Biological: Swine A/H1N1 influenza vaccine (split virion, inactivated);   Biological: Swine A/H1N1 influenza vaccine (split virion, inactivated)
6 Completed A Study of the Immunogenicity of Swine-origin A/H1N1 Influenza Vaccine in Healthy Adults
Conditions: Influenza;   Swine-origin A/H1N1 Influenza
Intervention: Biological: Swine A/H1N1 influenza vaccine (split virion, inactivated)
7 Completed
Has Results
Safety and Immunogenicity of H1N1 Vaccine With Trivalent Inactivated Seasonal Influenza Vaccine in Adults
Conditions: Influenza A Virus, H1N1 Subtype;   Influenza Infection
Interventions: Biological: GSK2340274A;   Biological: GSK2340273A;   Biological: Seasonal trivalent influenza vaccine (TIV);   Biological: Saline placebo
8 Completed Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Adults Receiving Seasonal Influenza Vaccine
Conditions: Influenza;   H1N1 2009 Influenza
Intervention: Biological: Arepanrix, Vaxigrip 2009/2010
9 Completed Evaluation of Pandemic Influenza A (H1N1) Vaccine in Chronic and or Immunocompromised Patients, Elderly and Pregnants
Conditions: Immunocompromised Patients;   Safety of Pandemic Influenza A (H1N1)Vaccine;   Immunogenicity of Pandemic Influenza A (H1N1)Vaccine
Intervention: Biological: Split inactivated A/California/7/2009 (H1N1) (NYMC X-179A) VIRUS
10 Completed Post Authorization Safety Study of the Pandemic A/H1N1 Influenza Vaccines in Children and Adults
Conditions: Influenza;   Swine-Origin A/H1N1 Influenza Virus
Intervention:
11 Completed Characteristics and Outcomes of Intensive Care Unit Patients Admitted With Novel H1N1 Influenza or Seasonal Influenza
Conditions: H1N1 Influenza;   Seasonal Influenza
Intervention:
12 Completed Novel Influenza A (H1N1) Surveillance Registry
Conditions: Novel Influenza A;   H1N1;   Influenza
Intervention:
13 Withdrawn Clinical Trial to Evaluate the Immunogenicity and Safety of the Vaccine Against Influenza A/H1N1
Condition: Influenza
Interventions: Biological: Vaccine Sanofi A(H1N1) 15 ug & trivalent;   Biological: Vaccine Sanofi (H1N1) 15 ug.nonadyuvante;   Biological: Vaccine Sanofi A(H1N1) 7.5 ug
14 Completed
Has Results
Safety and Immune Response of Candidate H1N1 Influenza Vaccine GSK2340274A Following Seasonal Influenza Vaccination in Adults
Condition: Influenza
Interventions: Biological: GSK Biologicals' FluLaval®;   Biological: Placebo (saline);   Biological: GSK Biologicals' investigational H1N1 Influenza Vaccine - GSK2340274A;   Biological: GSK Biologicals' investigational H1N1 Influenza Vaccine - GSK2340273A
15 Completed Safety and Immunogenicity Study of GSK Biologicals' Pandemic Influenza Candidate Vaccine (H1N1) (GSK2340272A)
Conditions: Influenza A Virus, H1N1 Subtype;   Influenza Infection
Intervention: Biological: Pandemic influenza vaccine GSK2340272A
16 Withdrawn Safety and Immune Response of One-Dose of Candidate H1N1 Influenza Vaccine GSK2340274A in Adults
Condition: Influenza
Intervention: Biological: GSK Biologicals' investigational H1N1 Influenza Vaccine - GSK2340274A
17 Completed Evaluation of Influenza H1N1 Vaccine in Adults With Lymphoid Malignancies on Chemotherapy
Conditions: Lymphoma;   Multiple Myeloma;   Influenza A Virus, H1N1 Subtype
Intervention: Biological: AS03-adjuvanted H1N1 pandemic influenza vaccine
18 Completed Observational Study to Assess Safety of H1N1 Pandemic Influenza Vaccine
Conditions: Influenza;   Pandemic Influenza
Intervention: Biological: H1N1 Pandemic Influenza Vaccine (whole virion, Vero Cell-derived, inactivated)
19 Completed Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Adults With HIV
Conditions: HIV Infections;   H1N1 Influenza
Intervention: Biological: Arepanrix
20 Completed Safety and Immunogenocity Study of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Japanese Children
Conditions: Influenza Infection;   Influenza Vaccines
Intervention: Biological: GSK Biologicals' Pandemic influenza (H1N1) candidate vaccine (GSK2340274A)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years